REQUEST A DEMO
Total
USD $0.00
Search more companies

B&C Biosciences S.A.S (Colombia)

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: B&C Biosciences S.A.S Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

B&C Biosciences S.A.S is a company based in Colombia, with its head office in Bogota D.C.. It operates in the Machinery, Equipment, and Supplies Merchant Wholesalers sector. The company was established on May 14, 2002. It currently has a total number of 28 (2026) employees. From the latest financial highlights, B&C Biosciences S.A.S reported a net sales revenue increase of 12.14% in 2025. Its’ total assets recorded a growth of 3.05%. The net profit margin of B&C Biosciences S.A.S increased by 0.71% in 2025.

Headquarters
Cra 19 # 58A-15
Bogota D.C.; Bogota D.C; Postal Code: 0214

Contact Details: Purchase the B&C Biosciences S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the B&C Biosciences S.A.S report to view the information.
Financial Auditors:
Purchase the B&C Biosciences S.A.S report to view the information.
Incorporation Date:
May 14, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after B&C Biosciences S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
12.14%
Total Operating Revenue
12.14%
Operating Profit
37.2%
Net Profit/Loss for the Period
28.15%
Total Assets
3.05%
Total Equity
25.28%
Operating Profit Margin
2.11%
Net Profit Margin
0.71%
Return on Equity (ROE)
0.45%
Quick Ratio
1.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?